APIs, Intermediates and Peptide Synthesis

Understanding APIs and Intermediates: The Building Blocks of Every Medicine

Behind every medicine on a pharmacy shelf is an ingredient that does the actual therapeutic work: the Active Pharmaceutical Ingredient (API). Understanding how APIs and their intermediates are produced helps brands make better sourcing and partnership decisions.

What is an API?

An API is the biologically active component of a drug product. In a paracetamol tablet, for example, paracetamol is the API, while the binders, fillers and coatings are excipients that help deliver it. The API determines the therapeutic effect, so its purity and consistency directly affect patient safety.

What are intermediates?

Most APIs are not made in a single step. They are built through a sequence of chemical reactions. The compounds produced along the way, before the final API is formed, are called intermediates. Advanced intermediates are those close to the final step and usually need tighter quality control.

How APIs are manufactured

  • Route selection: chemists choose a synthesis route that is safe, scalable and cost-effective.
  • Process development: reaction conditions, solvents and purification steps are optimised.
  • Scale-up: the process moves from lab to pilot to commercial reactors.
  • Purification and isolation: crystallisation, filtration and drying deliver the final API.
  • Testing and release: each batch is tested against specifications for identity, assay, impurities and residual solvents.

Why API quality matters

Impurities, polymorphic changes or batch-to-batch variation in an API can affect how a medicine dissolves, how stable it is and how safe it is. International guidance such as ICH Q7 sets out Good Manufacturing Practice expectations specifically for APIs, covering documentation, equipment, validation and change control.

Choosing an API partner

  • Documented GMP compliance and audit history
  • Strong impurity profiling and analytical capability
  • Reliable raw-material supply chain
  • Ability to provide technical documentation for regulatory filings

Marigold Pharma works on raw materials, APIs and intermediates, along with peptide and small-molecule synthesis. Explore our API capabilities or contact us to discuss your requirement.

Leave a comment

All fields marked with an asterisk (*) are required